ANAVEX LIFE SCIENCES CORP. Income Taxes Receivable, Current
ANAVEX LIFE SCIENCES CORP. (AVXL) had Income Taxes Receivable, Current of $995.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-28.
Financial Statements › Notes › Nontrade Receivables
us-gaap:IncomeTaxesReceivable · last filed 2026-08-28
- 2026-06-30: Income Taxes Receivable, Current $995.00K.
- 2026-03-31: Income Taxes Receivable, Current $932.00K.
- 2025-12-31: Income Taxes Receivable, Current $844.00K.
- 2025-09-30: Income Taxes Receivable, Current $809.00K.
| Period end | Income Taxes Receivable, Current | Income Taxes Receivable, Current as first filed |
|---|---|---|
| 2026-06-30 | $995.00K 10-Q · filed 2026-08-28 | |
| 2026-03-31 | $932.00K 10-Q · filed 2026-08-28 | |
| 2025-12-31 | $844.00K 10-Q · filed 2026-02-09 | |
| 2025-09-30 | $809.00K 10-K/A · filed 2026-08-28 | |
| 2025-06-30 | $820.00K 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $666.00K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $2.56M 10-Q · filed 2025-02-12 | |
| 2024-09-30 | $2.45M 10-K/A · filed 2026-08-28 | |
| 2024-06-30 | $1.72M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $3.79M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $3.55M 10-Q · filed 2024-02-07 | |
| 2023-09-30 | $2.71M 10-K · filed 2024-12-23 | |
| 2023-06-30 | $2.17M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $4.74M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $4.09M 10-Q · filed 2023-02-07 | |
| 2022-09-30 | $3.19M 10-K · filed 2023-11-27 | $3.19M 10-K · filed 2022-11-28 |
| 2022-06-30 | $6.56M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $6.47M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $5.37M 10-Q · filed 2022-02-09 | |
| 2021-09-30 | $9.14M 10-K · filed 2022-11-28 | |
| 2021-06-30 | $8.60M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $7.33M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $6.58M 10-Q · filed 2021-02-16 | |
| 2020-09-30 | $4.85M 10-K · filed 2021-11-24 | |
| 2020-06-30 | $3.55M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $4.15M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $3.73M 10-Q · filed 2020-02-06 | |
| 2019-09-30 | $2.64M 10-K · filed 2020-12-28 | |
| 2018-09-30 | $1.87M 10-K · filed 2019-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |